Although the growth conditions were different for the HepG2 and Bel7402 groups, LOXL2 promoted tumour growth in both the HepG2‐LOXL2 cell‐engrafted tumours and Bel7402‐control cell‐engrafted tumours. This evidence concerns the gene LOXL2 and neoplasm.